| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour
|
Satoh, Toyomi
|
|
2015
|
51 |
3 |
p. 340-351
12 p.
|
artikel
|
| 2 |
Analysis of patient-reported outcomes from the LUME-Lung 1 trial: A randomised, double-blind, placebo-controlled, Phase III study of second-line nintedanib in patients with advanced non-small cell lung cancer
|
Novello, Silvia
|
|
2015
|
51 |
3 |
p. 317-326
10 p.
|
artikel
|
| 3 |
Blinded double reading yields a higher programme sensitivity than non-blinded double reading at digital screening mammography: A prospected population based study in the south of The Netherlands
|
Klompenhouwer, Elisabeth G.
|
|
2015
|
51 |
3 |
p. 391-399
9 p.
|
artikel
|
| 4 |
Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer
|
Fakkert, Ingrid E.
|
|
2015
|
51 |
3 |
p. 400-408
9 p.
|
artikel
|
| 5 |
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trial
|
Mahner, Sven
|
|
2015
|
51 |
3 |
p. 352-358
7 p.
|
artikel
|
| 6 |
Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative
|
Bogaerts, Jan
|
|
2015
|
51 |
3 |
p. 271-281
11 p.
|
artikel
|
| 7 |
Differentially regulated miRNAs as prognostic biomarkers in the blood of primary CNS lymphoma patients
|
Roth, Patrick
|
|
2015
|
51 |
3 |
p. 382-390
9 p.
|
artikel
|
| 8 |
Evaluating iatrogenic prescribing: Development of an oncology-focused trigger tool
|
Hébert, Guillaume
|
|
2015
|
51 |
3 |
p. 427-435
9 p.
|
artikel
|
| 9 |
Mesenchymal chondrosarcoma: Prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study
|
Frezza, Anna Maria
|
|
2015
|
51 |
3 |
p. 374-381
8 p.
|
artikel
|
| 10 |
MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas
|
Gattolliat, Charles-Henry
|
|
2015
|
51 |
3 |
p. 409-420
12 p.
|
artikel
|
| 11 |
Overall survival in patients with a re-excision following breast conserving surgery compared to those without in a large population-based cohort
|
Vos, Elvira L.
|
|
2015
|
51 |
3 |
p. 282-291
10 p.
|
artikel
|
| 12 |
PACMEL: A phase 1 dose escalation trial of trametinib (GSK1120212) in combination with paclitaxel
|
Coupe, Nicholas
|
|
2015
|
51 |
3 |
p. 359-366
8 p.
|
artikel
|
| 13 |
PD-L1 expression in small cell neuroendocrine carcinomas
|
Schultheis, Anne M.
|
|
2015
|
51 |
3 |
p. 421-426
6 p.
|
artikel
|
| 14 |
Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors
|
Eckhoff, L.
|
|
2015
|
51 |
3 |
p. 292-300
9 p.
|
artikel
|
| 15 |
Survival of older patients with metastasised breast cancer lags behind despite evolving treatment strategies – A population-based study
|
de Glas, N.A.
|
|
2015
|
51 |
3 |
p. 310-316
7 p.
|
artikel
|
| 16 |
Systemic treatment of advanced hepatocellular carcinoma: From disillusions to new horizons
|
Hollebecque, Antoine
|
|
2015
|
51 |
3 |
p. 327-339
13 p.
|
artikel
|
| 17 |
Treatment modifications in tumour necrosis factor-α (TNF)-based isolated limb perfusion in patients with advanced extremity soft tissue sarcomas
|
Deroose, Jan P.
|
|
2015
|
51 |
3 |
p. 367-373
7 p.
|
artikel
|
| 18 |
Tumour size is the only predictive factor of distant recurrence after pathological complete response to neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancers: A sub-study of EORTC 10994/BIG 1-00 phase III trial
|
Fei, F.
|
|
2015
|
51 |
3 |
p. 301-309
9 p.
|
artikel
|
Tijdschrift beschrijving